4//SEC Filing
HUMPHREY RACHEL 4
Accession 0000899243-20-024836
CIK 0001701541other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 4:56 PM ET
Size
7.7 KB
Accession
0000899243-20-024836
Insider Transaction Report
Form 4
HUMPHREY RACHEL
Chief Medical Officer
Transactions
- Award
Common Stock
2020-09-08+10,000→ 10,000 total - Award
Stock Option (Right to Buy)
2020-09-08+150,000→ 150,000 totalExercise: $28.14Exp: 2030-09-08→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three equal annual installments, with the first installment commencing on September 8, 2021, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
- [F2]25% of this option shall vest and become exercisable on September 8, 2021, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001579781
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 4:56 PM ET
- Size
- 7.7 KB